Commentator: Shin Chung-chul, Director of Health Center, Ji-Pu Industrial Trend Research Institute

CAR-T therapy breaks new ground, sets record for longest remission period
CAR-T (Chimeric antigen receptor T cell) cell therapy is a new chapter. In addition to the well-known stories of Emily in the U.S. and the Taiwanese version of Emily's fight against blood cancers in the past, another case reported by the journals Nature and Nature Medicine reveals that in 2006, a girl who received experimental CAR-T cell therapy targeting GD2 against a common solid tumor in children had the longest remission period of cancer in 19 years. -T cell therapy, targeting GD2 to fight neuroblastoma, a common solid tumor in children, for 19 years without recurrence, setting a record for the longest period of cancer remission! In addition to injecting another shot in the arm for the field of cell therapy to completely cure cancer, whether it can be expanded from blood tumors to conquer solid tumors, which account for more than 90% of cancer patients, will be the focus of continuous attention of patients, medical professionals, and new cancer drug development companies around the world.